ScinoPharm will continue to exceed customer expectations and grow our competitive advantages to maintain our expertise and market leadership in Oncology APIs and services while provide sustained benefits for all stakeholders.
Interested investors can get
a quick information through this shareholder area.
ScinoPharm will keep the healthy decision and operation organization to continue upgrading the operation efficiency, and then apply actions to fulfill corporate governance.
Disclaimer: All information provided on ScinoPharm investor relations website is for informational purposes only, not intended for investment advice. Neither ScinoPharm nor any of independent providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein. By accessing this website, you agree not to redistribute the information found therein.
